is a partner of Arnold & Porter and co-chair of the firm's life sciences and healthcare regulatory practice. For decades, he has been one of the foremost Food and Drug Administration lawyers in the country, and his expertise in critical regulatory matters has been widely recognised by leading legal directories and publications. A particular focus of his practice is assisting pharmaceutical, biotechnology, medical device and diagnostic companies, including start-ups, trade associations and large manufacturers, in negotiating challenges relating to the development, approval and marketing of FDA-regulated products. Dan also has extensive experience in matters relating to foods, dietary supplements and cosmetics.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.